FusOn-pLM: Advancing Precision Therapy for Fusion Oncoproteins through Enhanced Protein Language Modeling
Fusion oncoproteins, formed by chromosomal translocations, are key drivers in many cancers, especially pediatric ones. These chimeric proteins are difficult ...
